EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
Allergen specific immunotherapy is the only currently available medical intervention that has the potential to affect the natural course of the disease. Allergen specific immunotherapy not only effectively alleviates allergy symptoms, but it has a long-term effect after conclusion of the treatment and can prevent the progression of allergic diseases. Moreover, specific products for allergen specific immunotherapy have shown to have disease-modifying capacities being able to prevent the progression of allergic diseases, as in the case of hay fever that may frequently lead to asthma and to reduce the risk of new sensitisations.